| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2008 | EP1877043A1 Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization |
| 01/16/2008 | EP1877041A2 Therapeutic compositions |
| 01/16/2008 | EP1877040A1 Extended release formulations |
| 01/16/2008 | EP1877039A1 Polyethylene glycol colonic purgative composition |
| 01/16/2008 | EP1877004A2 Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
| 01/16/2008 | EP1876906A1 Nutritional supplement or functional food comprising oil combination |
| 01/16/2008 | EP1876900A2 Phosphoinositide modulation for the treatment of alzheimer's disease |
| 01/16/2008 | EP1876894A1 Nucleoside compounds and methods of use thereof |
| 01/16/2008 | EP1876893A2 Cancer treatment by combined inhibition of proteasome and telomerase activities |
| 01/16/2008 | EP1789019B1 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 01/16/2008 | EP1786823B1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1773315B1 Arylacetic acids and related compounds for treatment of alzheimer's disease |
| 01/16/2008 | EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands |
| 01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
| 01/16/2008 | EP1711157A4 Composition for treating a dermatological inflammatory response and method of preparation thereof |
| 01/16/2008 | EP1701698B1 Directly compressible pharmaceutical composition for the oral admimistration of cci-779 |
| 01/16/2008 | EP1700159A4 Digital still camera with audio decoding and coding, a printable audio format, and method |
| 01/16/2008 | EP1694673B1 Thiazole derivates |
| 01/16/2008 | EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 01/16/2008 | EP1673063B1 Transdermal pharmaceutical composition |
| 01/16/2008 | EP1653947B1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivatives as estrogenic agents |
| 01/16/2008 | EP1644320B1 Indane derivates as muscarinic receptor agonists |
| 01/16/2008 | EP1636585B1 Diaryl ureas with kinase inhibiting activity |
| 01/16/2008 | EP1625126B1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 01/16/2008 | EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 01/16/2008 | EP1567486B1 Bis-aryl sulfonamides |
| 01/16/2008 | EP1562918B1 Substituted benzoxazinones and uses thereof |
| 01/16/2008 | EP1542904B1 Process for producing metered dose inhaler formulations |
| 01/16/2008 | EP1532154B1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1469823B1 Cosmetic or dermatological use of vitamin a or esters thereof in combination with a partially methylated beta-cyclodextrin |
| 01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1446095B1 Skin preparation comprising a tocopherol derivative for external application |
| 01/16/2008 | EP1435929B1 Composition comprising cysteamine for improving lactation in dairy animals |
| 01/16/2008 | EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 01/16/2008 | EP1399188B1 Perylenequinones for use as sonosensitizers |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1370254B1 Copper chelators for treating ocular inflammation |
| 01/16/2008 | EP1340748B1 Quinazoline derivatives and drugs |
| 01/16/2008 | EP1326639B1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1305311B1 Tartrate salt of thiazolidinedione derivative |
| 01/16/2008 | EP1282412B1 Treating irritable bowel syndrome or disease |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | EP1107969B1 Collections of compounds |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | EP1010701B1 Process for the preparation of 3-cephem compounds |
| 01/16/2008 | EP0938486B1 Substituted pyrrolopyrimidines and processes for their preparation |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0738141B1 Sucrose ester and n-docosanol formulations |
| 01/16/2008 | EP0620003B1 Vasopressin antagonist and oxytocin antagonist |
| 01/16/2008 | CN201006173Y Medicinal gloves for treating palm decortication |
| 01/16/2008 | CN201006015Y Nitroglycerin pad pasting |
| 01/16/2008 | CN101107261A Imidazopyridine derivative |
| 01/16/2008 | CN101107259A Silicon compounds and their use |
| 01/16/2008 | CN101107255A Anthelmintic imidazol-thiazole derivatives |
| 01/16/2008 | CN101107254A Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 01/16/2008 | CN101107253A Mitotic kinesin inhibitors |
| 01/16/2008 | CN101107252A Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases |
| 01/16/2008 | CN101107251A Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 01/16/2008 | CN101107250A Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 01/16/2008 | CN101107249A Purine derivatives acting as a2a receptor agonists |
| 01/16/2008 | CN101107248A 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitors of renin for the treatment of hypertension. |
| 01/16/2008 | CN101107247A Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 01/16/2008 | CN101107246A Anti-trypanosomiasis agent |
| 01/16/2008 | CN101107243A Substituted triazole derivatives as oxytocin antagonists |
| 01/16/2008 | CN101107242A 阿立哌唑的盐 Aripiprazole salt |
| 01/16/2008 | CN101107241A 氟烷基吡咯烷衍生物 Fluoroalkyl pyrrolidine derivative |
| 01/16/2008 | CN101107240A Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission |
| 01/16/2008 | CN101107239A N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists |
| 01/16/2008 | CN101107238A Asymmetric synthesis of dihydrobenzofuran derivatives |
| 01/16/2008 | CN101107237A Asymmetric synthesis of substituted dihydrobenzofurans |
| 01/16/2008 | CN101107236A Cyclohexylamides as dopamine D3, D2 and 5HT1A antagonists |
| 01/16/2008 | CN101107235A Morpholines as 5HT2C agonists |
| 01/16/2008 | CN101107234A HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives |
| 01/16/2008 | CN101107233A 1H-imidiazole derivatives as cannabinoid CB2 receptor modulators |
| 01/16/2008 | CN101107231A Imidazole and benzimidazole derivatives useful as histamine H3 antagonists |
| 01/16/2008 | CN101107228A Process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 01/16/2008 | CN101107227A 5-aminoindole derivatives |
| 01/16/2008 | CN101107226A Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 01/16/2008 | CN101107225A 12-aryl prostaglandin analogs |
| 01/16/2008 | CN101107224A Valnemulin salts with organic acids |
| 01/16/2008 | CN101107222A Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 01/16/2008 | CN101107220A Amide derivatives as inhibitors of histone deacetylase |
| 01/16/2008 | CN101107219A Compounds for treating urinary incontinence |
| 01/16/2008 | CN101107218A Novel dicarboxylic acid derivatives |
| 01/16/2008 | CN101107015A Injection for mastitis |
| 01/16/2008 | CN101107014A Stabilisation of glucocorticoid esters with acids |
| 01/16/2008 | CN101107013A Bioactive compositions |
| 01/16/2008 | CN101107004A Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |
| 01/16/2008 | CN101107002A Anthelmintic composition |
| 01/16/2008 | CN101107001A Anticancer drug containing alpha, alpha, alpha-trifluorothymidine and thymidine phosphorylase inhibitor |
| 01/16/2008 | CN101107000A 3,6-bicyclolides |
| 01/16/2008 | CN101106999A Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 CGMP phosphodiesterase inhibitor for the prevention and treatment of V |